Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fixed dose combination of cholinesterase inhibitor and a quaternary ammonium antimuscarinic agent to treat neurodegenerative cognitive disorders

Fixed dose combination of cholinesterase inhibitor and a quaternary ammonium antimuscarinic agent to treat neurodegenerative cognitive disorders

US Patent 12109202 · Granted Oct 8, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic t2022
Glycopyrronium fatty acid salts and methods of making same2019
Traffic cone2019
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic t2019
Traffic cone2019
Traffic cone2019
Quaternary ammonium anti-cholinergic muscarinic receptor antagonists2018
Traffic cone2017
Traffic cone2017
Traffic cone2017
Uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in 2015
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic t2015